• About
  • Advertise
  • Privacy & Policy
  • Contact
HK Businesswire
  • Home
  • News
    • All
    • Business
    • Politics
    • PR Newswire
    • Science
    • World
    Akeso Announces First Patient Enrolled in the Phase III Trial(AK112-312/HARMONi-GI6)of Ivonescimab for First-Line Treatment of Advanced Metastatic Colorectal Cancer

    Akeso Announces First Patient Enrolled in the Phase III Trial(AK112-312/HARMONi-GI6)of Ivonescimab for First-Line Treatment of Advanced Metastatic Colorectal Cancer

    JSRPM Leverages AI and Advanced Machining to Counter Tariff Pressures

    JSRPM Leverages AI and Advanced Machining to Counter Tariff Pressures

    AbbVie’s 10th ‘Week of Possibilities’ Unites Employees Across Asia for Community Impact

    AbbVie’s 10th ‘Week of Possibilities’ Unites Employees Across Asia for Community Impact

    ArkBio’s Ziresovir Included into Pediatric RSV Drug Priority List by WHO

    ArkBio’s Ziresovir Included into Pediatric RSV Drug Priority List by WHO

    TIER IV unveils end-to-end architecture for Level 4+ autonomy: To be demonstrated across 50 locations nationwide

    TIER IV unveils end-to-end architecture for Level 4+ autonomy: To be demonstrated across 50 locations nationwide

    Global Times: Xi’s vision of a people-centered city guides China’s urban development

    Global Times: Xi’s vision of a people-centered city guides China’s urban development

    Trending Tags

    • Trump Inauguration
    • United Stated
    • White House
    • Market Stories
    • Election Results
  • PR Newswire
  • Business
  • World
  • Entertainment
  • Sports
  • Tech
    • All
    • Apps
    • Gadget
    • Mobile
    • Startup

    Medisafe Scandal Deepens as HK Institutions Deny Outsourcing, Despite Contradictory Interview, Vendor Evidence and Whistleblower Claims

    Geneva Invention Awards Respond to Medisafe Scandal: ‘We Will Engage Our Own Panel to Determine Any Action’

    Deloitte: Over 40% of Family Offices Prioritise Tech Amid Digital Transformation

    PwC: AI-Exposed Jobs See Surge in Demand, Pay, and Productivity

    PwC: AI-Exposed Jobs See Surge in Demand, Pay, and Productivity

    Hong Kong Student Criticised for Using Outsourced AI Project to Win STEM Awards

    Xiaomi SU7 Ultra Becomes Fastest Mass-Produced EV on Nürburgring Nordschleife

    Trending Tags

    • Nintendo Switch
    • CES 2017
    • Playstation 4 Pro
    • Mark Zuckerberg
  • Feature
No Result
View All Result
  • Home
  • News
    • All
    • Business
    • Politics
    • PR Newswire
    • Science
    • World
    Akeso Announces First Patient Enrolled in the Phase III Trial(AK112-312/HARMONi-GI6)of Ivonescimab for First-Line Treatment of Advanced Metastatic Colorectal Cancer

    Akeso Announces First Patient Enrolled in the Phase III Trial(AK112-312/HARMONi-GI6)of Ivonescimab for First-Line Treatment of Advanced Metastatic Colorectal Cancer

    JSRPM Leverages AI and Advanced Machining to Counter Tariff Pressures

    JSRPM Leverages AI and Advanced Machining to Counter Tariff Pressures

    AbbVie’s 10th ‘Week of Possibilities’ Unites Employees Across Asia for Community Impact

    AbbVie’s 10th ‘Week of Possibilities’ Unites Employees Across Asia for Community Impact

    ArkBio’s Ziresovir Included into Pediatric RSV Drug Priority List by WHO

    ArkBio’s Ziresovir Included into Pediatric RSV Drug Priority List by WHO

    TIER IV unveils end-to-end architecture for Level 4+ autonomy: To be demonstrated across 50 locations nationwide

    TIER IV unveils end-to-end architecture for Level 4+ autonomy: To be demonstrated across 50 locations nationwide

    Global Times: Xi’s vision of a people-centered city guides China’s urban development

    Global Times: Xi’s vision of a people-centered city guides China’s urban development

    Trending Tags

    • Trump Inauguration
    • United Stated
    • White House
    • Market Stories
    • Election Results
  • PR Newswire
  • Business
  • World
  • Entertainment
  • Sports
  • Tech
    • All
    • Apps
    • Gadget
    • Mobile
    • Startup

    Medisafe Scandal Deepens as HK Institutions Deny Outsourcing, Despite Contradictory Interview, Vendor Evidence and Whistleblower Claims

    Geneva Invention Awards Respond to Medisafe Scandal: ‘We Will Engage Our Own Panel to Determine Any Action’

    Deloitte: Over 40% of Family Offices Prioritise Tech Amid Digital Transformation

    PwC: AI-Exposed Jobs See Surge in Demand, Pay, and Productivity

    PwC: AI-Exposed Jobs See Surge in Demand, Pay, and Productivity

    Hong Kong Student Criticised for Using Outsourced AI Project to Win STEM Awards

    Xiaomi SU7 Ultra Becomes Fastest Mass-Produced EV on Nürburgring Nordschleife

    Trending Tags

    • Nintendo Switch
    • CES 2017
    • Playstation 4 Pro
    • Mark Zuckerberg
  • Feature
No Result
View All Result
HK Businesswire
No Result
View All Result
Home News

HK to boost scrutiny of talent pass applications

Purton L by Purton L
12 April 2025
in News
0
HK to boost scrutiny of talent pass applications
0
SHARES
2
VIEWS
Share on FacebookShare on Twitter
Director of Immigration Benson Kwok says more officers will be deployed to verify documents submitted as part of Top Talent Pass Scheme applications, following reports of false information being provided on occasions.

“We will look into each case very carefully. Since June last year, we have been carrying out verification procedures for applicants’ academic qualifications,” he told reporters on Saturday.

“If verification procedures have not been carried out before, they will be conducted when applicants renew their pass.”

Meanwhile, Kwok also said national security risks persist in Hong Kong.

“The Immigration Department will not lower its guard, and it will make coordination actively on the implementation of the national security legislation,” he said.

“The department will continue to safeguard the southern gateway to our country and comprehensively block those who endanger national security from entering Hong Kong.”

Tags: Hong Konglocal
Purton L

Purton L

Read More

Akeso Announces First Patient Enrolled in the Phase III Trial(AK112-312/HARMONi-GI6)of Ivonescimab for First-Line Treatment of Advanced Metastatic Colorectal Cancer

Akeso Announces First Patient Enrolled in the Phase III Trial(AK112-312/HARMONi-GI6)of Ivonescimab for First-Line Treatment of Advanced Metastatic Colorectal Cancer

16 July 2025
JSRPM Leverages AI and Advanced Machining to Counter Tariff Pressures

JSRPM Leverages AI and Advanced Machining to Counter Tariff Pressures

16 July 2025
  • Trending
  • Comments
  • Latest
CreateAI Advances Generative AI Technology with Two Papers Accepted at Prestigious ICCV 2025

CreateAI Advances Generative AI Technology with Two Papers Accepted at Prestigious ICCV 2025

2 July 2025
Taylor’s University Continues Strong Global Performance in QS World University Rankings 2026

Taylor’s University Continues Strong Global Performance in QS World University Rankings 2026

23 June 2025

PwC: Hong Kong Set to Reclaim Global IPO Crown in 2025 as Fundraising Surges

3 July 2025
FORTUNE UNVEILS 2025 SOUTHEAST ASIA 500

FORTUNE UNVEILS 2025 SOUTHEAST ASIA 500

17 June 2025
Akeso Announces First Patient Enrolled in the Phase III Trial(AK112-312/HARMONi-GI6)of Ivonescimab for First-Line Treatment of Advanced Metastatic Colorectal Cancer

Akeso Announces First Patient Enrolled in the Phase III Trial(AK112-312/HARMONi-GI6)of Ivonescimab for First-Line Treatment of Advanced Metastatic Colorectal Cancer

16 July 2025
JSRPM Leverages AI and Advanced Machining to Counter Tariff Pressures

JSRPM Leverages AI and Advanced Machining to Counter Tariff Pressures

16 July 2025
AbbVie’s 10th ‘Week of Possibilities’ Unites Employees Across Asia for Community Impact

AbbVie’s 10th ‘Week of Possibilities’ Unites Employees Across Asia for Community Impact

16 July 2025
ArkBio’s Ziresovir Included into Pediatric RSV Drug Priority List by WHO

ArkBio’s Ziresovir Included into Pediatric RSV Drug Priority List by WHO

16 July 2025

Recent News

Akeso Announces First Patient Enrolled in the Phase III Trial(AK112-312/HARMONi-GI6)of Ivonescimab for First-Line Treatment of Advanced Metastatic Colorectal Cancer

Akeso Announces First Patient Enrolled in the Phase III Trial(AK112-312/HARMONi-GI6)of Ivonescimab for First-Line Treatment of Advanced Metastatic Colorectal Cancer

16 July 2025
JSRPM Leverages AI and Advanced Machining to Counter Tariff Pressures

JSRPM Leverages AI and Advanced Machining to Counter Tariff Pressures

16 July 2025
AbbVie’s 10th ‘Week of Possibilities’ Unites Employees Across Asia for Community Impact

AbbVie’s 10th ‘Week of Possibilities’ Unites Employees Across Asia for Community Impact

16 July 2025
ArkBio’s Ziresovir Included into Pediatric RSV Drug Priority List by WHO

ArkBio’s Ziresovir Included into Pediatric RSV Drug Priority List by WHO

16 July 2025
HK Businesswire

Stay ahead with the latest insights on Hong Kong’s economy, finance, and investments. From market trends to policy updates, we bring you in-depth analysis and expert opinions.

📩 Subscribe to our newsletter for exclusive updates.
📍 Follow us on social media for real-time news.
📧 Contact us: info@hongkong-invest.com

Follow Us

  • About
  • Advertise
  • Privacy & Policy
  • Contact

© 2025 by HKBusinesswire.com

No Result
View All Result

© 2025 by HKBusinesswire.com